With
such rich potential to deliver better health outcomes for Australians,
MTPConnect is a proud supporter of ANDHealth - Australia's only national
digital health accelerator - and its work with mid-stage digital health
companies.

One
such company is DoseMe which is developing a precision dosing platform.They were selected from over 50 companies to
participate in ANDHealth's first cohort and have utilised the program to drive
and inform its US market entry strategy.

DoseMe's
platform - DoseMeRx - is designed for clinicians at the point-of-care by using
readily available patient data. Using this platform, clinicians can make
real-time decisions on a patient's medication dosage and provide support from
just one blood sample. DoseMeRx virtually constructs a model of each patient's
individual pharmacokinetics. This allows
clinicians to predict the optimal dose of medication, taking away the
clinicians guess work and manual calculations.

"Unlike
many accelerators and grants which focus on very early stage ideas, ANDHealth
supports innovative companies like DoseMe to expand into other marketplaces and
sustain that growth," Mr Cornish explained.

"Developing
a strategy for DoseMe in partnership with a talented set of ANDHealth advisors,
with expertise ranging from clinical research through to pharmaceutical
marketing, is incredibly valuable as we continue to scale our operations."

DoseMe
has made considerable commercial progress throughout their participation in the
ANDHealth+ program. The company has successfully expanded their operations in
both Australia, the United States, South Africa, the United Kingdom,
Portugal, Brazil, Slovenia and Italy.

Managing
Director and Co-Founder of ANDHealth Bronwyn Le Grice says the ANDHealth+
program has provided its cohort with great opportunities and exposure to new
markets.

"ANDHealth
was established to help companies just like DoseMe," Ms Le Grice added.

"By
working closely alongside Charles and his team, the ANDHealth panel were able
to provide key insights and deliver key pieces of work which directly
contributed to the company's ability to scale internationally."

The
DoseMeRx platform was ranked in the top 20 2018 Hot Apps for healthcare
providers by Health Data Management. They also developed and validated a
SMART-on-FHIR application available in both Cerner and Epic App stores.